Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Evaluation of Gemtuzumab Ozogamicin and Anthracycline Dosing for Favorable Risk Acute Myeloid Leukemia.
Mort JF, Brighton D, DiBenedetto S, Wells L, Clark SM, Reid J, Patel I, Jackson C, Yelvington B, Miller R, Perciavalle M, Walsh K, Wolfe H, Locke SC, Zeidner JF, Duong VH, Reed DR, Dholaria B, LeBlanc TW, Keng M, Horton B, El Chaer F. Mort JF, et al. Among authors: perciavalle m. Eur J Haematol. 2024 Nov 27. doi: 10.1111/ejh.14354. Online ahead of print. Eur J Haematol. 2024. PMID: 39601208
Clinician and administrator perspectives on outpatient administration of ciltacabtagene autoleucel in relapsed or refractory multiple myeloma.
Hansen DK, Dhakal B, Hamadani M, Dingli D, Jain T, Huff CA, Janakiram M, Liu YH, De Braganca KC, Lodowski N, Sander J, Okorozo P, McFarland L, Perciavalle M, Huo S, Qureshi ZP, Patel KK. Hansen DK, et al. Among authors: perciavalle m. Front Immunol. 2024 Jun 10;15:1405452. doi: 10.3389/fimmu.2024.1405452. eCollection 2024. Front Immunol. 2024. PMID: 38915401 Free PMC article.